Case report: Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient

American Journal of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 2014, Pages 81-83

  Tuon, Felipe F ^a   Bombonatto, Giovana Marina ^b   Battaglin, Eveline Roesler ^b   Sakumoto, Marcus Henrique ^b   Amato, Valdir Sabbaga ^c   Abegão De Camargo, Raphael ^c   Nicodemo, Anton̂io Carlos ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; IMMUNOSUPPRESSIVE AGENT;

AGED; AMASTIGOTE; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHEMA; FATALITY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LEISHMANIA BRAZILIENSIS; NOSE EDEMA; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; SEPTIC SHOCK; SKIN DEFECT; SKIN LEISHMANIASIS; DRUG EFFECT; PATHOGENICITY; PHYSIOLOGY; TREATMENT FAILURE;

AGED; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; TREATMENT FAILURE;

EID: 84903902718     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0578     Document Type: Article

References (10)

1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581-596. (Pubitemid 47277438)
2. Tuon FF, Amato VS, Floeter-Winter LM, de Andrade Zampieri R, Amato Neto V, Siqueira França FO, Shikanai-Yasuda MA, 2007. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids-first report. Int J Dermatol 46: 628-630. (Pubitemid 46909410)
3. Oliveira-Neto MP, Mattos M, Souza CS, Fernandes O, Pirmez C, 1998. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 37: 846-849. (Pubitemid 28545279)
4. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M, 2008. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8: 191-199. (Pubitemid 351249252)
5. Batista MV, Pierrotti LC, Abdala E, Clemente WT, Girão ES, Rosa DR, Ianhez LE, Bonazzi PR, Lima AS, Fernandes PF, Pádua-Neto MV, Bacchella T, Oliveira AP, Viana CF, Ferreira MS, Shikanai-Yasuda MA, 2011. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 16: 1134-1142.
6. Tuon FF, Gomes-Silva A, Da-Cruz AM, Duarte MI, Neto VA, Amato VS, 2008. Local immunological factors associated with recurrence of mucosal leishmaniasis. Clin Immunol 128: 442-446.
7. Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Amato Neto V, 2007. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 77: 266-274. (Pubitemid 351859275)
8. Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato NV, 2008. Treatment of New World cutaneous leishmaniasis - a systematic review with a meta-analysis. Int J Dermatol 47: 109-124.
9. Amato VS, Tuon FF, Campos A, Bacha HA, Nicodemo AC, Neto VA, Shikanai-Yasuda MA, 2007. Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. Clin Infect Dis 44: 311-312. (Pubitemid 46080001)
10. Amato VS, Tuon FF, Camargo RA, Souza RM, Santos CR, Nicodemo AC, 2011. Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis? Am J Trop Med Hyg 85: 818-819.